KOSDAQ - Delayed Quote KRW

Englewood Lab, Inc. (950140.KQ)

10,370.00
-110.00
(-1.05%)
At close: 3:30:23 PM GMT+9
Loading Chart for 950140.KQ
  • Previous Close 10,480.00
  • Open 10,480.00
  • Bid 10,310.00 x --
  • Ask 10,370.00 x --
  • Day's Range 10,220.00 - 10,960.00
  • 52 Week Range 6,410.00 - 28,300.00
  • Volume 375,648
  • Avg. Volume 536,655
  • Market Cap (intraday) 206.03B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield 100.33 (0.96%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est 13,000.00

Englewood Lab, Inc. engages in the development, manufacture, marketing, sale, and distribution of cosmetic products in the United States, Canada, China, Korea, Europe, Southeast Asia, and internationally. It also provides testing and research services to other furniture companies. The company was founded in 2015 and is headquartered in Totowa, New Jersey.

www.englewoodlab.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 950140.KQ

View More

Performance Overview: 950140.KQ

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

950140.KQ
52.05%
MSCI WORLD (^990100-USD-STRD)
3.24%

1-Year Return

950140.KQ
34.78%
MSCI WORLD (^990100-USD-STRD)
10.24%

3-Year Return

950140.KQ
49.64%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

950140.KQ
124.46%
MSCI WORLD (^990100-USD-STRD)
90.59%

Compare To: 950140.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 950140.KQ

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    208.22B

  • Enterprise Value

    199.77B

  • Trailing P/E

    10.67

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.15

  • Price/Book (mrq)

    1.45

  • Enterprise Value/Revenue

    1.10

  • Enterprise Value/EBITDA

    6.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.44%

  • Return on Assets (ttm)

    5.37%

  • Return on Equity (ttm)

    12.13%

  • Revenue (ttm)

    172.17B

  • Net Income Avi to Common (ttm)

    16.26B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    39.85B

  • Total Debt/Equity (mrq)

    20.73%

  • Levered Free Cash Flow (ttm)

    -2.32B

Research Analysis: 950140.KQ

View More

Company Insights: 950140.KQ

Research Reports: 950140.KQ

View More

People Also Watch